Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aurinia Pharm Ord
(NQ:
AUPH
)
7.030
-0.150 (-2.09%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aurinia Pharm Ord
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
These 2 Healthcare Stocks Have Doubled in 2023
February 01, 2023
Wouldn’t it be great if a stock had a bulkier capitalization and 2x potential? This is rare but possible for these two small-mid health care stocks.
Via
MarketBeat
Aurinia Announces PTAB Has Terminated Inter Partes Review
January 25, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis From the United States Patent and Trademark Office
January 24, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Shares of Aurinia Pharmaceuticals Soared This Week
January 06, 2023
A patent settlement and improved financials sent the stock soaring.
Via
The Motley Fool
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-year 2022 Net Revenue Results
January 06, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals to Present at Upcoming 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
January 04, 2023
Via
Benzinga
Tesla, Amazon, Apple, Aurinia Pharma, Vera Therapeutics: Why These 5 Stocks Are Drawing Investors' Attention Today
January 03, 2023
Major Wall Street indices closed in the red on Tuesday, the first trading day of 2023, as concerns over rising rates and inflation still seem to drive investor sentiments.
Via
Benzinga
Why Is Aurinia Pharmaceuticals (AUPH) Stock Down 30%?
November 03, 2022
Despite strong Q3 earnings, shares of AUPH stock are in steep decline today after it lowered its full-year sales guidance.
Via
InvestorPlace
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 03, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Horizon Global Shares Are Trading Higher By Over 340%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 03, 2023
Gainers Horizon Global Corporation (NYSE: HZN) shares surged 341% to $1.7161 after the company announced it will be acquired by First Brands Group.
Via
Benzinga
Aurinia Announces LUPKYNIS® (voclosporin) Patent Challenge Settlement Reached With Sun Pharmaceuticals
January 03, 2023
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
November 30, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
What 4 Analyst Ratings Have To Say About Aurinia Pharmaceuticals
November 04, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
November 04, 2022
Upgrades
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 03, 2022
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!
Via
InvestorPlace
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
November 04, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.
Via
Benzinga
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
November 03, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Via
Benzinga
Recap: Aurinia Pharmaceuticals Q3 Earnings
November 03, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results
November 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Earnings Preview For Aurinia Pharmaceuticals
November 02, 2022
Aurinia Pharmaceuticals (NASDAQ:AUPH) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022
October 28, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals Announces Presentations at American Society of Nephrology (ASN) Kidney Week 2022
October 27, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
October 24, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via
Benzinga
Aurinia Reports New Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Pharmaceuticals Announces Presentations at American College of Rheumatology (ACR) Convergence 2022
September 20, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
Aurinia Announces European Commission Approval of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
September 19, 2022
From
Aurinia Pharmaceuticals Inc.
Via
Business Wire
NASDAQ: AUPH Long Term Investor Alert: Investigation of Potential Wrongdoing at Aurinia Pharmaceuticals Inc.
August 15, 2022
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- Certain directors of Aurinia Pharmaceuticals Inc. are under investigation over possible breaches of fiduciary duties.
Via
SBWire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.